Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Occurrence of metabolic syndrome in midlife in relation to cardiovascular morbidity and all-cause mortality-lessons from a population-based matched cohort study with 27 years follow-up
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland.ORCID iD: 0000-0003-4706-6915
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland.ORCID iD: 0000-0003-1433-0329
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland.ORCID iD: 0000-0002-6833-8783
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland.ORCID iD: 0000-0001-9927-2660
Show others and affiliations
2024 (English)In: BMJ Open, E-ISSN 2044-6055, Vol. 14, no 9, article id e081444Article in journal (Refereed) Published
Abstract [en]

Objectives: We examined how asymptomatic metabolic syndrome (MetS) in midlife affects cardiovascular (CV) morbidity and all-cause mortality later in life and studied difference in time to event and from the individual components related to MetS.

Design: Population-based matched cohort study including data from a screening programme for identification of CV risk factors.

Setting: Primary care, County of Vastmanland, Sweden.

Participants: All inhabitants turning 40 or 50 years between 1990 and 1999 were invited to a health screening. Total 34 269 (60.1%) individuals completed the health examination. Participants that met a modified definition of MetS were individually matched to two controls without MetS with regard to age, sex and date of health examination.

Interventions: None.

Main outcome measures: CV events and all-cause mortality from the index examination to June 2022.

Results: All 5084 participants with MetS were matched to two controls. There were 1645 (32.4%) CV events in the MetS group and 2321 (22.8%) CV events for controls. 1317 (25.9%) MetS and 1904 (18.7%) control subjects died. The adjusted HRs (aHR) for CV event and death were significantly higher when MetS was present (aHR) 1.39*** (95% CI 1.28 to 1.50) and 1.27*** (95% CI 1.16 to 1.40) respectively. The factor analysis identified three dominating factors: blood pressure, cholesterol and blood glucose. Mean time for first CV event and death was 2.6 years and 1.5 years shorter respectively for participants within the highest quartile compared with participants with lower mean arterial blood pressure (MAP). The aHR for each 10 mm Hg increased MAP were 1.19*** (95% CI 1.15 to 1.23) for CV event and 1.16*** (95% CI 1.11 to 1.21) for death.

Conclusion: The risk of a CV event and premature death is significantly increased when MetS is present. Early detection of metabolic risk factors, especially, high blood pressure, opens a window of opportunity to introduce preventive treatment to reduce CV morbidity and all-cause mortality.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2024. Vol. 14, no 9, article id e081444
Keywords [en]
Hypertension, Factor Analysis, Statistical, Primary Health Care, Risk Factors, Diabetes & endocrinology
National Category
Cardiology and Cardiovascular Disease Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-541509DOI: 10.1136/bmjopen-2023-081444ISI: 001337275200001PubMedID: 39284695OAI: oai:DiVA.org:uu-541509DiVA, id: diva2:1910558
Available from: 2024-11-05 Created: 2024-11-05 Last updated: 2025-02-10Bibliographically approved

Open Access in DiVA

fulltext(1703 kB)274 downloads
File information
File name FULLTEXT01.pdfFile size 1703 kBChecksum SHA-512
847a02900ca90eaa3d91dae8798dd5f481ffa7cbde4ff4f5f4caf46a26cd0ad0384914bff5f8bdcde62e2e1c55b6fc693b28f9aeb6faaab5c4578101b6351de6
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Lönnberg, LenaLeppert, JerzyÖhrvik, JohnRehn, MattiasChabok, AbbasDamberg, Mattias

Search in DiVA

By author/editor
Lönnberg, LenaLeppert, JerzyÖhrvik, JohnRehn, MattiasChabok, AbbasDamberg, Mattias
By organisation
Centre for Clinical Research, County of VästmanlandDepartment of Public Health and Caring Sciences
In the same journal
BMJ Open
Cardiology and Cardiovascular DiseaseEndocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 274 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 229 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf